72 Investment Holdings’s Turnstone Biologics TSBX Stock Holding History

72 Investment Holdings’s Portfolio TSBX Stock Details TSBX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q3	–	Sell	-549,980	Closed	-$197K	–	6
2025 Q2	$197K	Hold	549,980	–	–	0.52%	6
2025 Q1	$225K	Hold	549,980	–	–	0.63%	6
2024 Q4	$273K	Hold	549,980	–	–	0.56%	6
2024 Q3	$306K	Hold	549,980	–	–	0.66%	7
2024 Q2	$1.44M	Sell	549,980 -1	-0%	-$3	3.62%	5
2024 Q1	$1.44M	Hold	549,981	–	–	2.15%	6
2023 Q4	$1.4M	Hold	549,981	–	–	6.22%	5
2023 Q3	$2.17M	Buy	+549,981	New	+$4.9M	14.52%	3

72 Investment Holdings's TSBX Position: Q3 2025 in Review

72 Investment Holdings sold out of Turnstone Biologics (TSBX) in Q3 2025, closing a stake of 549,980 shares — an estimated $197K sold.

72 Investment Holdings first reported a position in TSBX in Q3 2023 and held it in 8 quarters. The position peaked at $2.17M in Q3 2023. 1 fund tracked by Wall St. Rank holds TSBX as of Q3 2025.

72 Investment Holdings reported no remaining Turnstone Biologics position as of Q3 2025 after selling out during the quarter.
72 Investment Holdings sold 549,980 Turnstone Biologics shares in Q3 2025, an estimated $197K.
72 Investment Holdings first reported a position in Turnstone Biologics in Q3 2023 and held it in 8 quarters.
72 Investment Holdings's Turnstone Biologics position peaked at $2.17M in Q3 2023.
1 fund tracked by Wall St. Rank held Turnstone Biologics as of Q3 2025.

Based on 72 Investment Holdings's 13F filing for Q3 2025, filed 14 Nov 2025.